Risk of nephrogenic systemic fibrosis after exposure to newer gadolinium agents
Thus, synthesizing the existing evidence about the safety profile of newer, and presumably more stable, GBCAs across the spectrum of kidney function could inform clinical policies. The goal of this report is to provide a systematic review of the existing evidence on the risk of NSF with use of newer...
| Main Authors: | , |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Washington, D.C.
U.S. Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service
October 2019, 2019
|
| Series: | Evidence synthesis program
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references